Clinical Trial Update: Physician Initiated Expanded Access Request for Migalastat in Individual Patients With Fabry Disease

View source ↗

Summary

A physician-initiated expanded access request for migalastat in individual Fabry disease patients is being tracked, with the program listed as available.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fabry Disease

Drugs mentioned

• Migalastat (migalastat)

Snippet

Sponsor: Amicus Therapeutics | Conditions: Fabry Disease | Status: AVAILABLE